secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2024-10-11T23:59:59+00:00
Accession:  0000950170-24-114315
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.02, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRACON fails to achieve quorum for liquidation vote; adjourns special meeting to Nov 12
--------------------------------------------------------------------------------

- Special meeting to vote on dissolution had only 294,397 shares present; quorum not met.
- CEO Craig R. Jalbert acquired a single Super-Voting Share for $0.01, with extra votes only on dissolution.
- Bylaws amended: quorum now requires majority of voting power, not majority of outstanding shares.
- Super-Voting Share cannot be transferred without board consent; ranks senior to common on liquidation.
- Adjourned special meeting scheduled for November 12, 2024 to achieve quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024114315/0000950170-24-114315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024114315/tcon-20241011.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-114315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer